Unaudited Financial Results for the quarter and half year ended 30th September, 2025.

Revenue declinedNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.80

prior close

₹0.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-0.6% vs market

Pharmaceuticals peers, median of 157sector+0.1%-0.1% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+1.3

30m

+1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.6-0.6+0.1-0.1

Next day

-1.3-0.2-1.0-0.7-0.6

-3.8-0.4-3.4-1.1-2.7

-5.0-0.7-4.3-0.9-4.1

+3.8-2.2+6.0-2.0+5.7

+7.5-2.8+10.3-3.2+10.7

+0.0-1.4+1.4-2.2+2.2

15d

-16.3-7.0-9.2-4.7-11.5

-20.0-6.1-13.9-5.0-15.0

-37.5-9.2-28.3-7.6-29.9

-42.5-6.8-35.7-9.5-33.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Rajnish Wellness reported weak Q2 FY26 results, with revenue from operations falling to Rs. 1,200.42 lakhs from Rs. 1,741.91 lakhs in the year-ago quarter — a sharp drop of about 31%. Profit after tax for the quarter shrank to Rs. 6.47 lakhs versus Rs. 27.77 lakhs previously. For the half year, revenue declined roughly 51% to Rs. 1,656.04 lakhs and PAT fell to Rs. 27.98 lakhs from Rs. 44.45 lakhs. The company raised Rs. 24.69 crore via a Rights Issue in August 2025, but only Rs. 83.8 lakhs has been deployed so far (towards general corporate purposes), with the rest sitting as investments and receivables. Operating cash flow turned deeply negative at Rs. -2,394.32 lakhs compared to a small positive Rs. 4.41 lakhs last year, driven mainly by a Rs. 666 lakh jump in receivables and Rs. 1,449 lakh deployed into investments.

Likely market impact

Shareholders should note deteriorating top-line and profitability along with a steeply negative operating cash flow, indicating that growth has stalled and working capital is being stretched. However, the fresh Rights Issue funds provide a cash cushion for now, and management has flagged no deviation in the stated use of proceeds.